Key result
Single LDL apheresis significantly increased coronary flow velocity reserve from 1.78 at baseline to 2.10 (P < 0.001) in patients with familial hypercholesterolemia.
Why the study?
Does single LDL apheresis improve coronary flow velocity reserve in patients with familial hypercholesterolemia and significant coronary stenosis?
Does single LDL apheresis improve coronary flow velocity reserve in patients with familial hypercholesterolemia and significant coronary stenosis?
Absolute Event Rate: 2.1% vs 1.78%
p-value: p=< 0.001
Single LDL apheresis acutely improves coronary flow velocity reserve in patients with familial hypercholesterolemia, likely due to epicardial coronary artery dilatation and improved microvessel function.
UNLABELLED: The purpose of this study was to clarify whether coronary flow velocity reserve (CFVR), evaluated by adenosine 5'-triphosphate-induced hyperemia, is improved by single low-density lipoprotein (LDL) apheresis. Lipid lowering therapy is known to improve endothelium-dependent vasodilatation in forearm or coronary resistant vessels. However, few reports have studied the effect of acute LDL reduction on CFVR. METHODS: Seven patients with familial hypercholesterolemia and significant coronary stenosis except in the left anterior descending artery (LAD) were enrolled in this study. Coronary flow velocity reserve was estimated before and after LDL apheresis using transthoracic Doppler echocardiography (TTDE), which detects the flow velocity at the distal site of the LAD. Although the averaged diastolic peak velocity (ADPV) during ATP-induced hyperemia was similar before and after LDL apheresis, the ADPV at baseline decreased from 30.69 to 25.56 cm/s, resulting in an increased CFVR from 1.78 to 2.10 (P < 0.001). Plasma bradykinin and 6 keto PGF1alpha increased while fibrinogen and plasma viscosity decreased after apheresis. Single LDL apheresis improves CFVR according to TTDE analysis because of the decreasing ADPV at baseline, which is thought to be induced by epicardial coronary artery dilatation and improved microvessel function. This is the result of various factors, such as changes in plasma LDL cholesterol, bradykinin and PGI2 levels with LDL apheresis.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2004) studied Familial hypercholesterolemia and significant coronary stenosis (n=7). Single low-density lipoprotein (LDL) apheresis vs. Baseline (before apheresis) was evaluated on Coronary flow velocity reserve (CFVR) (p=< 0.001). Single LDL apheresis significantly increased coronary flow velocity reserve from 1.78 at baseline to 2.10 (P < 0.001) in patients with familial hypercholesterolemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: